Back to today’s briefing

Story perspectives

Moderna Delays Combined Flu-COVID Vaccine for Adults Over 50

5/22/2025

45 6

Summary

Story summary

Moderna has pulled back its application for a combined flu and COVID-19 vaccine for adults over 50, intending to resubmit later this year with updated efficacy data. This move comes after the FDA mandated new clinical trials for annual COVID-19 boosters, as Moderna seeks to rejuvenate its vaccine sales with innovative mRNA solutions.

1 of 1

Story summary

Moderna has pulled back its application for a combined flu and COVID-19 vaccine for adults over 50, intending to resubmit later this year with updated efficacy data. This move comes after the FDA mandated new clinical trials for annual COVID-19 boosters, as Moderna seeks to rejuvenate its vaccine sales with innovative mRNA solutions.